http://www.biocentury.com () —
BioCentury Publications, Inc., the leading global provider of biotechnology news and analysis, and W…USA-TV, the Washington, D.C., CBS affiliate and flagship television station of Gannett Broadcasting, have partnered to present BioCentury This Week. This weekly public affairs program will examine how the intersection of biotechnology with industry, public policy, regulation and finance will transform healthcare, food, energy and the environment.
BioCentury This Week joins the CBS "Sunday Power Block" lineup that includes CBS Sunday Morning, Face the Nation, This Week in Defense News, Platt's Energy Week, and The McLaughlin Group.
The first public affairs program of its kind to be broadcast on a major U.S. television station, BioCentury This Week premieres September 19, from 8:30-9:00 A.M. EDT, on WUSA Channel 9 in the Washington, D.C., market and on Fox affiliate WFXT Channel 25 in the Boston, Mass., market.
For its global audience, the weekly programs will be continuously streamed from the BioCentury This Week website, biocenturytv.com, starting Sunday, September 19, at 9:00 a.m.
BioCentury This Week will be anchored by Washington Editor Steve Usdin and Publisher Eric Pierce, both 18-year veterans of BioCentury. They will be supported by BioCentury's network of senior scientific and business editors, recognized for their deep knowledge and understanding of biotechnology: its science, its history and its players.
The development of BioCentury This Week will be overseen by BioCentury's founders, Chairman & Editor-in-Chief Karen Bernstein, Ph.D., and President & CEO David Flores, both globally recognized for their efforts to provide an objective, accurate and authoritative information platform for key decision makers in bioindustry.
"BioCentury This Week is a unique content platform, presenting highly topical information from biotechnology policy makers, corporate decision makers and key industry opinion leaders," said Allan Horlick, President and General Manager of W…USA-TV. "It will offer an unprecedented environment for reaching biotechnology stakeholders."
According to David Flores, President & CEO of BioCentury, "There is a clear unmet need for the public and policy makers to understand how politics, regulatory decisions, investor attitudes, bioethics and global competition will determine whether bioscience fulfills its social promise. BioCentury and W…USA will fill this need."
BioCentury This Week will continue BioCentury's independent approach to spotlight the views of key scientific opinion leaders, corporate decision makers, lawmakers and policy architects, venture capitalists and other investment professionals, and the patient and consumer groups who stand to benefit most from biotechnology.
The Charter Sponsors of BioCentury This Week include Biogen Idec Inc., a global leader in the discovery, development, manufacturing and marketing of innovative therapies, creating new standards of care in oncology, neurology and immunology; the Biotechnology Industry Organization (BIO), an industry trade association representing more than 1,200 biotechnology companies, academic institutions and related organizations in the U.S. and 30 countries; and Rodman & Renshaw, a full-service investment bank providing corporate finance, strategic advisory and related services to public and private companies.
About BioCenturyNow in its 18th year, BioCentury Publications, Inc. is internationally recognized as the leading provider of news, analysis and opinion about biotechnology, including emerging technology, product development, industry strategy and finance, regulation and public policy. The company publishes the weekly journal BioCentury: The Bernstein Report on BioBusiness and BioCentury Extra, a daily online newspaper. BioCentury also publishes SciBX: Science Business eXchange, a translational science journal in partnership with Nature Publishing Group, and markets BCIQ: BioCentury Online Intelligence, a data solutions product for biopharma industry and investment professionals. The company is widely acknowledged in the life science corporate and investment communities for pioneering the creation of three annual conferences that provide turf-neutral venues in the U.S. and Europe for biopharma investors, pharmaceutical licensing professionals and corporate executives to conduct business. BioCentury is headquartered in Redwood City, Calif., with offices in Washington, D.C., Chicago, Chadds Ford, Penn., and London.
About W…USAW…USA is owned by the Gannett Company Inc. (NYSE: GCI). Gannett is an international news and information company operating on multiple platforms including the Internet, mobile, newspapers, magazines and TV stations. Gannett is an Internet leader with hundreds of newspaper and TV Web sites; CareerBuilder.com, the nation's top employment site; USATODAY.com; and more than 80 local MomsLikeMe.com sites. Gannett publishes 84 daily U.S. newspapers, including USA TODAY, the nation's largest-selling daily newspaper, and more than 700 magazines and other non-dailies including USA WEEKEND. Gannett also operates 23 television stations in 19 U.S. markets. Gannett subsidiary Newsquest is the United Kingdom's second largest regional newspaper company with 17 daily paid-for titles, more than 200 weekly newspapers, magazines and trade publications, and a network of Web sites. Gannett TV stations are: WATL-TV, Atlanta, GA, WXIA-TV, Atlanta, GA, WLBZ-TV, Bangor, Maine, WGRZ-TV, Buffalo, N.Y., WKYC-TV, Cleveland, Ohio, WLTX-TV, Columbia, S.C., KTVD-TV, Denver, Colo., KUSA-TV, Denver, Colo., KNAZ-TV, Flagstaff, Ariz., WZZM-TV, Grand Rapids-Kalamazoo-Battle Creek, Mich., WFMY-TV, Greensboro, N.C., WTLV-TV, Jacksonville, Fla., WJXX-TV, Jacksonville, Fla., WBIR-TV, Knoxville, Tenn., KTHV-TV, Little Rock, Ark., WMAZ-TV, Macon, Ga., KARE-TV, Minneapolis-St. Paul, MN, KPNX-TV, Phoenix, Ariz., WCSH-TV, Portland, Maine, KXTV-TV, Sacramento, Calif., KSDK-TV, St. Louis, Mo., WTSP-TV, Tampa-St. Petersburg, Fla., WUSA-TV, Washington, D.C.